Japanese Journal of Clinical Oncology 31:74-81 (2001)
© 2001 Foundation for Promotion of Cancer Research
A Study of Pretreatment Nomograms to Predict Pathological Stage and Biochemical Recurrence After Radical Prostatectomy for Clinically Resectable Prostate Cancer in Japanese Men
Departments of 1Urology and 4Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa and Departments of 2Urology and 3Pathology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan
Background: Accurate pretreatment identification of the risks that prostate cancer has extended beyond the gland and that it will recur would significantly influence practice patterns. Preoperative nomograms to predict such risks have not been developed for the oriental male population.
Methods: Construction of nomograms to predict preoperatively pathological outcome and early biochemical failure following radical prostatectomy in Japanese males was based on logistic regression analysis, with predicted probabilities and 95% confidence intervals for the final model being obtained by repeating the analysis on 1000 bootstrap samples from the original cohort.
Results: Prostate-specific antigen level, clinical stage and biopsy Gleason score contributed significantly to the prediction of pathological stage and of biochemical failure in the univariate analysis (p < 0.001). Combined use of these three variables predicted these treatment outcomes better than any single variable (p < 0.001). Nomograms combining these three variables to predict final pathological findings and early biochemical failure were then developed. The medians and 95% confidence intervals of the predicted probabilities are presented in the nomograms.
Conclusions: This information enables clinicians to use their nomograms when counseling Japanese patients, leading to more informed treatment decisions and helping to identify those with a high risk of early biochemical failure. The nomograms may also be used to assure comparability of different treatment modalities in investigational trials.
+ For reprints and all correspondence: Shin Egawa, Department of Urology, Kitasato University School of Medicine, 1151 Kitasato, Sagamihara, Kanagawa 228-8555, Japan. E-mail: s-egpro@sa2.so-net.ne.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Nakamura, K. Ogawa, T. Yamamoto, T. Sasaki, M. Koizumi, T. Teshima, T. Inoue, and the Japanese PCS Working Subgroup of Prostate Canc Trends in the Practice of Radiotherapy for Localized Prostate Cancer in Japan: a Preliminary Patterns of Care Study Report Jpn. J. Clin. Oncol., October 1, 2003; 33(10): 527 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsui, S. Egawa, C. Tsukayama, A. Terai, S. Kuwao, S. Baba, and Y. Arai Artificial Neural Network Analysis for Predicting Pathological Stage of Clinically Localized Prostate Cancer in the Japanese Population Jpn. J. Clin. Oncol., December 1, 2002; 32(12): 530 - 535. [Abstract] [Full Text] [PDF] |
||||
